CClinicalTrials.gg
CompletedNCT03233581Updated May 25, 2018

Improving Physical Activity in Young Adult Cancer Survivors

An interventional study of Fitbit + Facebook + Coaching Group and Fitbit only in Physical Activity and Quality of Life, sponsored by Seattle Children's Hospital. Completed at 2 sites in United States. Open to participants aged 18 Years to 39 Years, including healthy volunteers. Per ClinicalTrials.gov, last updated 2018-05-25.

Sponsored by Seattle Children's Hospital · Not applicable, Interventional, and Treatment

Phase
Not applicable
Study type
Interventional
Enrollment
50
Allocation
Randomized
Ages
18 Years to 39 Years
Sex
All
01

Study summary

The Primary Goal is to conduct a 12 week pilot randomized controlled trial (RCT) of the Fitbit Flex, a popular, affordable, wearable physical activity tracking device, and the Fitbit mobile health (mHealth) app. The target population will be cancer survivors 18-39 years old recruited from the Seattle Cancer Care Alliance. For the intervention group, peer influences will be engaged via a private, social network (e.g. a Facebook group) customized for survivors. Measurements will be completed (1) at baseline, prior to randomization, and (2) during the final week of the intervention period (follow-up measure). This pilot study will provide initial proof of concept and allow for further customization of the intervention for cancer survivors in anticipation of a future, larger proposal to study physical activity and related outcomes over a multi-year period.

Besides conducting exploratory analyses of primary and secondary outcomes for this pilot RCT, we also specify feasibility criteria including: (1) recruiting 50 cancer survivors ages 18-39 years and between 1.0-5.0 years from the completion of active cancer therapy, (2) intervention participants wear the Fitbit Flex on the majority of all intervention days during the 12-week intervention period, and (3) ≥75% of all participants complete online questionnaire data collection at Time 1 and Time 2.

02

Conditions studied

  • Physical Activity
  • Quality of Life
03

In context

Lead sponsor

Seattle Children's Hospital is the lead sponsor of 210 studies on the registry; 43 are open to participants now.

Counted across the registry records on this site, refreshed daily.

04

Who can participate

Ages eligible
18 Years to 39 Years
Sexes eligible
All
Accepts healthy volunteers
Yes

Inclusion criteria

  • Does not meet recommended guidelines for physical activity (PA,150 min of moderate activity or 75 min of vigorous activity)
  • Currently between 1.0-5.0 years from the completion of active cancer therapy
  • Able to read and speak English
  • Have a smart phone (or can borrow a study-provided iPod Touch) and willing to use it for the mobile app and Facebook group

Exclusion criteria

Exclusion Criteria:

  • Pregnant or planning on becoming pregnant in the next year
05

Study design

Phase
Not applicable
Primary purpose
Treatment
Allocation
Randomized
Intervention model
Parallel assignment
Masking
Single (Investigator)
Enrollment
50 participants (actual)

Study arms

  • Experimental
    Fitbit + Facebook + Health Coaching

    Participants will use the Fitbit device and join the Facebook group. They will also receive brief weekly health coaching from a research staff. Participants will select an adult family member or friend to also receive a Fitbit during the intervention period to provide them with support.

    Behavioral: Fitbit + Facebook + Coaching Group

  • Active comparator
    Usual care control with Fitbit only

    Participants will be loaned a Fitbit device only. They will not join the Facebook group nor receive health coaching. They will not select an adult family member or friend to receive a Fitbit device to provide them with support.

    Behavioral: Fitbit only

Interventions

  • BehavioralFitbit + Facebook + Coaching Group

    Participants will use the FitBit device to track their physical activity (PA). Participants will receive and post messages and receive badges on the Facebook group. Weekly a research staff member will call them to provide brief health coaching. Participants will select an adult family member or friend to also receive a Fitbit during the intervention period to provide support.

  • BehavioralFitbit only

    Participants will receive a Fitbit device only, and will not receive health coaching, join the Facebook group, or select an adult family member or friend to receive a Fitbit to provide them with support.

06

What researchers measure

Primary outcomes

  1. Post-intervention physical activity (minutes per day of moderate-to-vigorous physical activity objectively measured by accelerometers)

    Time frame: up to week 12

Secondary outcomes

  1. Post-intervention health related quality of life (measured by questionnaire)

    Time frame: up to week 12

  2. Self-determination theory constructs (measured by the Behavioral Regulation in Exercise Questionnaire 2)

    Time frame: up to week 12

07

Study locations

2 sites
  • Fred Hutchinson Cancer Research Center
    Seattle, Washington 98109, United States
  • Seattle Children's Research Institute
    Seattle, Washington 98145-5005, United States
08

References and documents

Publications

  • Johnson AM, Baker KS, Haviland MJ, Syrjala KL, Abbey-Lambertz M, Chow EJ, Mendoza JA. A Pilot Randomized Controlled Trial of a Fitbit- and Facebook-Based Physical Activity Intervention for Young Adult Cancer Survivors. J Adolesc Young Adult Oncol. 2022 Aug;11(4):379-388. doi: 10.1089/jayao.2021.0056. Epub 2021 Oct 22. PubMed 34677081 ↗
  • Miropolsky EM, Scott Baker K, Abbey-Lambertz M, Syrjala K, Chow EJ, Ceballos R, Mendoza JA. Participant Perceptions on a Fitbit and Facebook Intervention for Young Adult Cancer Survivors: A Qualitative Study. J Adolesc Young Adult Oncol. 2020 Jun;9(3):410-417. doi: 10.1089/jayao.2019.0072. Epub 2020 Jan 13. PubMed 31928489 ↗

Individual participant data

Plan to share: No

09

Updates

Tracking since Sep 25, 2026
No changes since tracking began. The registry record was last updated on May 25, 2018, before this site started recording changes on Sep 25, 2026. Its history is on ClinicalTrials.gov ↗
10

Registry details

Key details

Study ID
NCT03233581
Lead sponsor
Seattle Children's Hospital
Collaborators
Fred Hutchinson Cancer Center
Responsible party
Jason Mendoza (Investigator and Associate Professor of Pediatrics, Seattle Children's Hospital) — Principal investigator
First posted
Jul 28, 2017
Start date
Sep 12, 2017
Primary completion
May 6, 2018
Completion
May 22, 2018
Last update
May 25, 2018

Oversight

Data monitoring committee
No
FDA-regulated drug
No
FDA-regulated device
No
View the source record on ClinicalTrials.gov ↗

Not currently enrolling

This study is completed, as verified in May 2018. You cannot join it, but the record below documents what was studied.

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Start the discussion